近日,普众发现公司研究团队在Cancer Discovery(IF=38.272)杂志在线发表题为“Antibody-exatecan conjugates with a novel self-immolative moiety overcome resistance in colon and lung cancer”的研究论文,详尽揭示了DS-8201a(及其他DXd家族ADC)和TR
深刻并准确理解DS-8201a或TRODELVY的耐药机制成为变得需要和迫切。 近日,普众发现(Multitude Therapeutics)公司研究团队在Cancer Discovery杂志在线发表题为“Antibody-exatecan conjugates with a novel self-immolative moiety overcome resistance in colon and lung cancer”的研究论文,详尽揭示了DS-8201a(及其他DXd家族ADC...